Diagnostics

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Lighten and Datavant have teamed up to turn messy medical notes into regulatory-grade data, aiming to dramatically speed up life sciences research.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

The biotech firm raises cash via a complex warrant deal, diluting shares to fund its promising but challenging RNAi therapy for deadly KRAS-driven cancers.

A key workshop aims to bridge the gap between FDA policy and patient needs, seeking to streamline therapy development for millions with rare diseases.

Koelis launches ProMap® Smart, an AI software that contours the prostate in under 5 seconds, boosting biopsy precision and streamlining patient care.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

Beyond just tracking data, SIBIONICS's new AI tools aim to tell diabetes patients what to do next, heralding a new era of personalized care.

A landmark partnership will deploy SC Johnson's innovative, electricity-free Guardian repellent, aiming to protect millions from malaria in Sub-Saharan Africa.

A new campaign is challenging perceptions of Alzheimer's, but it's fueled by more than stories. It's a nexus of new drugs, blood tests, and patient advocacy.

A new tool from a national lab uses de-identified test data to give health officials an early warning on emerging disease threats like pertussis and flu.

The Virginia-based startup landed a major funding round to automate liquid biopsy sample prep, aiming to make cancer detection faster and more reliable.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

From malaria vaccines to maglev trains, 12 finalists are celebrated for breakthroughs tackling the world's most pressing environmental and health crises.

From over 134,000 applicants, ten nurses are finalists for a $250K prize, shining a light on their work and the challenges facing the global nursing profession.

A new partnership provides sexual assault survivors with private, lab-accurate STI tests they can use at home, getting results in 30 minutes.

Fueled by personal tragedy and backed by tech titans, a new foundation aims to revolutionize lung cancer detection using AI and genetics for non-smokers.

A new fluid that eliminates ultrasound 'noise' during brain tumor removal could give surgeons a clearer view, promising better outcomes for patients.